MAGNANI CHIARA FRANCESCA

Pubblicazioni

  • Magnani, C., Mezzanotte, C., Cappuzzello, C., Bardini, M., Tettamanti, S., Fazio, G., et al. (2018). Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia. HUMAN GENE THERAPY, 29(5), 602-613. Dettaglio
  • Fazio, G., Turazzi, N., Cazzaniga, V., Kreuzaler, M., Maglia, O., Magnani, C., et al. (2018). TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 182(3), 434-436. Dettaglio
  • Turazzi, N., Fazio, G., Rossi, V., Rolink, A., Cazzaniga, G., Biondi, A., et al. (2018). Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 182(6), 939-943. Dettaglio
  • Arcangeli, S., Rotiroti, M., Bardelli, M., Simonelli, L., Magnani, C., Biondi, A., et al. (2017). Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia. MOLECULAR THERAPY, 25(8), 1933-1945. Dettaglio
  • Biondi, A., Magnani, C., Tettamanti, S., Gaipa, G., & Biagi, E. (2017). Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia. JOURNAL OF AUTOIMMUNITY, 85, 141-152. Dettaglio